US Patent Issued to REGENERON PHARMACEUTICALS on March 24 for "Bispecific antigen binding molecules that bind HER2, and methods of use thereof" (New York, Delaware Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,939, issued on March 24, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Bispecific antigen binding molecules that bind HER2, and methods of use thereof" was invented by Julian Andreev (Sleepy Hollow, N.Y.), Andres Perez Bay (New York), Christopher Daly (New York), Frank Delfino (Poughquag, N.Y.), Amy Han (Hockessin, Del.), Thomas Nittoli (Pearl River, N.Y.), William Olson (Yorktown Heights, N.Y.) and Gavin Thurston (Briarcliff Manor, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are bispecific antigen-binding molecules that bind HER2 and methods of use thereof. The bispecific antigen-binding molecules compr...